Fundraising Fox

Collegium Pharmaceutical

NASDAQ: COLL

Canton, US · Virginia corporation · 4 known investors

collegiumpharma.com ↗
Biotechin /collegium-pharmaceutical@CollegiumPharma

Founders & leadership

GS
Gino SantiniDirector
EN
Eran NadavDirector
JF
John FreundDirector
PH
Patrick HeronDirector
GB
Garen BohlinDirector
DH
David HirschDirector
MH
Michael HeffernanExecutive Officer, Director
PB
Paul BrannellyExecutive Officer

Investors · 4

APERTURE Venture PartnersBoston · $1M – $5M
EcoR1 CapitalSan Francisco
Frazier Life SciencesPalo Altovia Patrick Heron · board
Longitude CapitalMenlo Park · $10M – $30M

Reported raises · per SEC filings

Form D private placements
▶$20MraisedNov 2018 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael HeffernanDirector
  • David HirschDirector
  • Garen BohlinDirector
  • Shirley KuhlmannExecutive Officer
  • Theodore SchroederDirector
  • John A FallonDirector
  • Alison B. FlemingExecutive Officer
  • Gwen MelincoffDirector
  • Gino SantiniDirector
  • Scott DreyerExecutive Officer
  • Joseph CiaffoniExecutive Officer, Director
  • John FreundDirector
  • Paul BrannellyExecutive Officer
Offering amount
$20M
Amount sold
$20M
First sale
Nov 2018
Incorporated
Corporation, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedMar 2015 · 18 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gino SantiniDirector
  • Eran NadavDirector
  • John FreundDirector
  • Patrick HeronDirector
  • Garen BohlinDirector
  • David HirschDirector
  • Michael HeffernanExecutive Officer, Director
  • Paul BrannellyExecutive Officer
Offering amount
$50M
Amount sold
$50M
First sale
Mar 2015
Incorporated
Corporation, Virginia
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.